Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


08.05.2017

1 Am J Surg
6 Ann Oncol
3 BMC Cancer
1 Br J Cancer
4 Br J Surg
1 Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Med Insights Oncol
15 Dis Colon Rectum
2 Gastroenterology
5 Int J Cancer
2 Int J Colorectal Dis
2 Int J Oncol
1 J Clin Oncol
1 Lancet Oncol
1 Oncogene
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. MCCOLL RJ, McGahan CE, Cai E, Olson R, et al
    Impact of hospital volume on quality indicators for rectal cancer surgery in British Columbia, Canada.
    Am J Surg. 2017;213:388-394.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. AUCLIN E, Zaanan A, Vernerey D, Douard R, et al
    Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.
    Ann Oncol. 2017;28:958-968.
    PubMed     Text format     Abstract available

  3. ROHR UP, Herrmann P, Ilm K, Zhang H, et al
    Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies.
    Ann Oncol. 2017 Apr 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. DIENSTMANN R, Mason MJ, Sinicrope FA, Phipps AI, et al
    Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
    Ann Oncol. 2017;28:1023-1031.
    PubMed     Text format     Abstract available

  5. SUENAGA M, Schirripa M, Cao S, Zhang W, et al
    Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
    Ann Oncol. 2017;28:1015-1022.
    PubMed     Text format     Abstract available

  6. FONT R, Espinas JA, Layos L, Martinez Villacampa M, et al
    Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?
    Ann Oncol. 2017;28:831-835.
    PubMed     Text format     Abstract available

  7. BUDHATHOKI S, Iwasaki M, Yamaji T, Yamamoto H, et al
    Association of plasma concentrations of branched-chain amino acids with risk of colorectal adenoma in a large Japanese population.
    Ann Oncol. 2017;28:818-823.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. KONDO Y, Hayashi K, Kawakami K, Miwa Y, et al
    KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer.
    BMC Cancer. 2017;17:311.
    PubMed     Text format     Abstract available

  9. XIE M, Qin H, Luo Q, Huang Q, et al
    MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.
    BMC Cancer. 2017;17:305.
    PubMed     Text format     Abstract available

  10. TAYLOR SA, Mallett S, Miles A, Beare S, et al
    Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
    BMC Cancer. 2017;17:299.
    PubMed     Text format     Abstract available


    Br J Cancer

  11. DYER KE, Dumenci L, Siminoff LA, Thomson MD, et al
    The contribution of body mass index to appraisal delay in colorectal cancer diagnosis: a structural equation modelling study.
    Br J Cancer. 2017 May 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Surg

  12. BORSTLAP WA, Coeymans TJ, Tanis PJ, Marijnen CA, et al
    Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.
    Br J Surg. 2016;103:1105-16.
    PubMed     Text format     Abstract available

  13. WATANABE J, Ota M, Fujii S, Suwa H, et al
    Randomized clinical trial of single-incision versus multiport laparoscopic colectomy.
    Br J Surg. 2016;103:1276-81.
    PubMed     Text format     Abstract available

  14. HALLET J, Sa Cunha A, Adam R, Goere D, et al
    Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Br J Surg. 2016;103:1366-76.
    PubMed     Text format     Abstract available

  15. MERKEL S, Weber K, Matzel KE, Agaimy A, et al
    Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2016;103:1220-9.
    PubMed     Text format     Abstract available


    Cancer

  16. RICE K, Gressard L, DeGroff A, Gersten J, et al
    Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30761.
    PubMed     Text format     Abstract available


    Cancer Lett

  17. DU C, Huang D, Peng Y, Yao Y, et al
    5-Fluorouracil Targets Histone Acetyltransferases p300/CBP in the Treatment of Colorectal Cancer.
    Cancer Lett. 2017 Apr 29. pii: S0304-3835(17)30294.
    PubMed     Text format     Abstract available


    Cancer Res

  18. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


    Clin Med Insights Oncol

  19. AUGESTAD KM, Merok MA, Ignatovic D
    Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.
    Clin Med Insights Oncol. 2017;11:1179554917690766.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  20. MAHMOUD NN
    Development of the American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist.
    Dis Colon Rectum. 2016;59:587-8.
    PubMed     Text format    

  21. GLASGOW SC, Morris AM, Baxter NN, Fleshman JW, et al
    Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist.
    Dis Colon Rectum. 2016;59:601-6.
    PubMed     Text format     Abstract available

  22. EFTAIHA SM, Pai A, Sulo S, Park JJ, et al
    Robot-Assisted Abdominoperineal Resection: Clinical, Pathologic, and Oncologic Outcomes.
    Dis Colon Rectum. 2016;59:607-14.
    PubMed     Text format     Abstract available

  23. TRILLING B, Cotte E, Vaudoyer D, Isaac S, et al
    Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
    Dis Colon Rectum. 2016;59:615-22.
    PubMed     Text format     Abstract available

  24. STORNES T, Wibe A, Nesbakken A, Myklebust TA, et al
    National Early Rectal Cancer Treatment Revisited.
    Dis Colon Rectum. 2016;59:623-9.
    PubMed     Text format     Abstract available

  25. CHONG CS, Huh JW, Oh BY, Park YA, et al
    Operative Method for Transverse Colon Carcinoma: Transverse Colectomy Versus Extended Colectomy.
    Dis Colon Rectum. 2016;59:630-9.
    PubMed     Text format     Abstract available

  26. AL-NAJAMI I, Beets-Tan RG, Madsen G, Baatrup G, et al
    Dual-Energy CT of Rectal Cancer Specimens: A CT-based Method for Mesorectal Lymph Node Characterization.
    Dis Colon Rectum. 2016;59:640-7.
    PubMed     Text format     Abstract available

  27. NEWTON AD, Li J, Jeganathan AN, Mahmoud NN, et al
    A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2016;59:710-7.
    PubMed     Text format     Abstract available

  28. PEREZ RO, Habr-Gama A, Sao Juliao GP, Vailati BB, et al
    Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?
    Dis Colon Rectum. 2016;59:895-7.
    PubMed     Text format    

  29. KALADY MF
    Lessons Learned From the Quest for Gene Signatures That Predict Treatment Response in Rectal Cancer.
    Dis Colon Rectum. 2016;59:898-900.
    PubMed     Text format    

  30. TINMOUTH J, Peeva V, Amare H, Blitz S, et al
    Progression From Perianal High-Grade Anal Intraepithelial Neoplasia to Anal Cancer in HIV-Positive Men Who Have Sex With Men.
    Dis Colon Rectum. 2016;59:836-42.
    PubMed     Text format     Abstract available

  31. ADAM JP, Denost Q, Capdepont M, van Geluwe B, et al
    Prospective and Longitudinal Study of Urogenital Dysfunction After Proctectomy for Rectal Cancer.
    Dis Colon Rectum. 2016;59:822-30.
    PubMed     Text format     Abstract available

  32. COLOV EP, Klein M, Gogenur I
    Wound Complications and Perineal Pain After Extralevator Versus Standard Abdominoperineal Excision: A Nationwide Study.
    Dis Colon Rectum. 2016;59:813-21.
    PubMed     Text format     Abstract available

  33. DOS ANJOS DA, Perez RO, Habr-Gama A, Sao Juliao GP, et al
    Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dis Colon Rectum. 2016;59:805-12.
    PubMed     Text format     Abstract available

  34. ZHANG G, Cai YZ, Xu GH
    Diagnostic Accuracy of MRI for Assessment of T Category and Circumferential Resection Margin Involvement in Patients With Rectal Cancer: A Meta-Analysis.
    Dis Colon Rectum. 2016;59:789-99.
    PubMed     Text format     Abstract available


    Gastroenterology

  35. MURPHY CC, Lund JL, Sandler RS
    Young-onset colorectal cancer: earlier diagnoses or increasing disease burden?
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35539.
    PubMed     Text format    

  36. MOSS A, Nalankilli K
    The Association Between Diet and Colorectal Cancer Risk - Moving Beyond Generalisations.
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35534.
    PubMed     Text format    


    Int J Cancer

  37. ERTEM FU, Zhang W, Chang K, Mohaiza Dashwood W, et al
    Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
    Int J Cancer. 2017;140:460-468.
    PubMed     Text format     Abstract available

  38. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available

  39. KUAN FC, Lai CH, Ku HY, Wu CF, et al
    The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Int J Cancer. 2017;140:1662-1669.
    PubMed     Text format     Abstract available

  40. JAYASEKARA H, MacInnis RJ, Williamson EJ, Hodge AM, et al
    Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
    Int J Cancer. 2017;140:1485-1493.
    PubMed     Text format     Abstract available

  41. BJERRUM A, Andersen O, Fischer A, Lindebjerg J, et al
    Long term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30756.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  42. NG JY, Chan DK, Tan KK
    Is gastroscopy for fecal immunochemical test positive patients worthwhile?
    Int J Colorectal Dis. 2017;32:95-98.
    PubMed     Text format     Abstract available

  43. ORMSBY NM, Bermingham HN, Joshi HM, Chadwick M, et al
    The significance of extramural venous invasion in R1 positive rectal cancer.
    Int J Colorectal Dis. 2017;32:119-124.
    PubMed     Text format     Abstract available


    Int J Oncol

  44. ZHAO J, Li G, Bo W, Zhou Y, et al
    Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis.
    Int J Oncol. 2017;50:613-621.
    PubMed     Text format     Abstract available

  45. CHUNG SS, Oliva B, Dwabe S, Vadgama JV, et al
    Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
    Int J Oncol. 2016;49:487-98.
    PubMed     Text format     Abstract available


    J Clin Oncol

  46. VAN DE WAL M, Thewes B, Gielissen M, Speckens A, et al
    Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
    J Clin Oncol. 2017 May 4:JCO2016705301. doi: 10.1200/JCO.2016.70.5301.
    PubMed     Text format     Abstract available


    Lancet Oncol

  47. ATKIN W, Wooldrage K, Brenner A, Martin J, et al
    Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.
    Lancet Oncol. 2017 Apr 27. pii: S1470-2045(17)30187.
    PubMed     Text format     Abstract available


    Oncogene

  48. PEK M, Yatim SMJM, Chen Y, Li J, et al
    Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  49. KIM HJ, Jo MJ, Kim BR, Kim JL, et al
    Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
    PLoS One. 2017;12:e0176834.
    PubMed     Text format     Abstract available

  50. SHIN SJ, Chun SM, Kim TI, Kim YJ, et al
    Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping.
    PLoS One. 2017;12:e0176340.
    PubMed     Text format     Abstract available

  51. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: